organization · Reporting owner
Medpace Investors, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | 10% owner | March 06, 2024 | March 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date March 06, 2024 · Filed March 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,733,019 |
Ending reported balance
After 2024-03-08 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-03-06 · Sale · Disposed 100,000 · Balance 4,833,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. Row 2 · 2024-03-07 · Sale · Disposed 75,000 · Balance 4,758,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. Row 3 · 2024-03-08 · Sale · Disposed 25,000 · Balance 4,733,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2019 Filed Nov 19, 2019 21:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 518 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-021861 · doc1.xml · derivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,301 Underlying: Common Stock · 518 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 555 | $16.20 | $8,991.00 |
DisclosureSEC source: 0001567619-19-021861 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,760,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 518 | $14.41 | $7,464.38 |
DisclosureSEC source: 0001567619-19-021861 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,760,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,851 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-19-018793 · doc1.xml · derivative · entry 6 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,414 Underlying: Common Stock · 1,851 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,222 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-018793 · doc1.xml · derivative · entry 5 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,813 Underlying: Common Stock · 2,222 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,313 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-018793 · doc1.xml · derivative · entry 4 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,819 Underlying: Common Stock · 4,313 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 1,851 | $16.20 | $29,986.20 |
DisclosureSEC source: 0001567619-19-018793 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,759,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 2,222 | $14.41 | $32,019.02 |
DisclosureSEC source: 0001567619-19-018793 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,757,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 4,313 | $14.41 | $62,150.33 |
DisclosureSEC source: 0001567619-19-018793 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,755,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2019 Filed Nov 19, 2019 21:13 UTC Amendment | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,851 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-19-021858 · doc1.xml · derivative · entry 4 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,414 Underlying: Common Stock · 1,851 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Correction due to administrative error. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| September 24, 2019 Filed Nov 19, 2019 21:13 UTC Amendment | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,222 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-021858 · doc1.xml · derivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,813 Underlying: Common Stock · 2,222 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Correction due to administrative error. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| September 24, 2019 Filed Nov 19, 2019 21:13 UTC Amendment | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,313 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-021858 · doc1.xml · derivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,819 Underlying: Common Stock · 4,313 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Correction due to administrative error. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:50 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 11,112 | $36.77 Strike: $18.23 | $408,588.24 |
DisclosureSEC source: 0001567619-19-018435 · doc1.xml · derivative · entry 6 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,112 Underlying: Common Stock · 11,112 shares Expires 2023-03-31 F1 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F2 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable. F1 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:50 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 10,887 | $38.12 Strike: $16.88 | $415,012.44 |
DisclosureSEC source: 0001567619-19-018435 · doc1.xml · derivative · entry 5 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,887 Underlying: Common Stock · 10,887 shares Expires 2022-07-31 F1 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F2 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable. F1 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:50 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 73,265 | $38.80 Strike: $16.20 | $2,842,682.00 |
DisclosureSEC source: 0001567619-19-018435 · doc1.xml · derivative · entry 4 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,265 Underlying: Common Stock · 73,265 shares Expires 2022-03-31 F1 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F2 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable. F1 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:50 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 17,035 | $40.59 Strike: $14.41 | $691,450.65 |
DisclosureSEC source: 0001567619-19-018435 · doc1.xml · derivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,035 Underlying: Common Stock · 17,035 shares Expires 2021-07-07 F1 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F2 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable. F1 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:50 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 117,132 | $40.59 Strike: $14.41 | $4,754,387.88 |
DisclosureSEC source: 0001567619-19-018435 · doc1.xml · derivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,132 Underlying: Common Stock · 117,132 shares Expires 2021-06-10 F1 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F2 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable. F1 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 18,920 | $66.54 | $1,258,936.80 |
DisclosureSEC source: 0001567619-19-002368 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,751,125 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $66.07 to $67.60. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 84,093 | $65.54 | $5,511,455.22 |
DisclosureSEC source: 0001567619-19-002368 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,770,045 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $63.61 to $66.775. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 31, 2019 Filed Jan 31, 2019 21:52 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 68,383 | $64.19 | $4,389,504.77 |
DisclosureSEC source: 0001567619-19-002036 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,854,138 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $63.32 to $64.86. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 30, 2019 Filed Jan 31, 2019 21:52 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 102,828 | $63.22 | $6,500,786.16 |
DisclosureSEC source: 0001567619-19-002036 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,922,521 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $64.43. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 29, 2019 Filed Jan 31, 2019 21:52 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,100 | $61.05 | $67,155.00 |
DisclosureSEC source: 0001567619-19-002036 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,025,349 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.18. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 28, 2019 Filed Jan 28, 2019 21:56 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 4,221 | $61.04 | $257,649.84 |
DisclosureSEC source: 0001567619-19-001783 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,026,449 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.19. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 25, 2019 Filed Jan 28, 2019 21:56 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 27,958 | $61.13 | $1,709,072.54 |
DisclosureSEC source: 0001567619-19-001783 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,030,670 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.60. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 24, 2019 Filed Jan 28, 2019 21:56 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,501 | $61.14 | $214,051.14 |
DisclosureSEC source: 0001567619-19-001783 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,058,628 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 23, 2019 Filed Jan 23, 2019 21:47 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 24,160 | $61.22 | $1,479,075.20 |
DisclosureSEC source: 0001567619-19-001505 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,062,129 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.79. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 22, 2019 Filed Jan 23, 2019 21:47 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 9,936 | $61.10 | $607,089.60 |
DisclosureSEC source: 0001567619-19-001505 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,086,289 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.31. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:47 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 38,318 | $61.43 | $2,353,874.74 |
DisclosureSEC source: 0001567619-19-001505 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,096,225 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.91. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 17, 2019 Filed Jan 17, 2019 21:41 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 8,760 | $61.17 | $535,849.20 |
DisclosureSEC source: 0001567619-19-001303 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,134,543 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.34. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 16, 2019 Filed Jan 17, 2019 21:41 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,222 | $61.57 | $444,658.54 |
DisclosureSEC source: 0001567619-19-001303 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,143,303 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $62.07. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:41 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 600 | $61.00 | $36,600.00 |
DisclosureSEC source: 0001567619-19-001303 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,150,525 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 20:34 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | OtherCommon Stock | 748,459 | $59.91 | $44,840,178.69 |
DisclosureSEC source: 0001567619-18-003359 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,147,051 F1 · kind: Represents distributions of MEDP shares in-kind to the holders of the Reporting Person's Incentive Units. F1 · shares: Represents distributions of MEDP shares in-kind to the holders of the Reporting Person's Incentive Units. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 20:52 UTC Amendment | Medpace Holdings, Inc. MEDP · Entity 3327 | OtherCommon Stock | 747,454 | $59.91 | $44,779,969.14 |
DisclosureSEC source: 0001567619-18-003529 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,148,056 F1 · kind: Represents distributions of MEDP shares in-kind to the holders of the Reporting Person's Incentive Units. F2 · shares: Amendment to Form 4 filing dated October 1, 2018 to report adjusted amount of shares distributed. Read SEC document |
| September 28, 2018 Filed Oct 11, 2018 20:32 UTC Amendment | Medpace Holdings, Inc. MEDP · Entity 3327 | OtherCommon Stock | 744,385 | $59.91 | $44,596,105.35 |
DisclosureSEC source: 0001567619-18-003992 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,151,125 F1 · kind: Represents distributions of MEDP shares in-kind to the holders of the Reporting Person's Incentive Units. F2 · shares: Second amendment to Form 4 filing dated October 1, 2018 to report adjusted amount of shares distributed. Read SEC document |
| September 27, 2018 Filed Sep 27, 2018 20:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 46,778 | $58.96 | $2,758,030.88 |
DisclosureSEC source: 0001567619-18-003212 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,895,510 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $59.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 26, 2018 Filed Sep 27, 2018 20:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 46,886 | $58.38 | $2,737,204.68 |
DisclosureSEC source: 0001567619-18-003212 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,942,288 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $59.29. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 20:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 38,640 | $58.36 | $2,255,030.40 |
DisclosureSEC source: 0001567619-18-003212 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,989,174 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $58.82. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 21, 2018 Filed Sep 24, 2018 20:31 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 2,713 | $58.47 | $158,629.11 |
DisclosureSEC source: 0001567619-18-003046 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,027,814 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.22 to $58.57. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 20, 2018 Filed Sep 21, 2018 22:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 53,842 | $58.29 | $3,138,450.18 |
DisclosureSEC source: 0000899243-18-025028 · doc4.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,030,527 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $58.74. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 22:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 61,141 | $60.20 | $3,680,810.48 |
DisclosureSEC source: 0000899243-18-025028 · doc4.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,084,369 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $64.47. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 31, 2017 Filed Aug 9, 2018 20:56 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | OtherCommon Stock | 37,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-000255 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,145,510 F2 · kind: Issuer shares were disposed of by the Reporting Person through an in-kind exchange of Class B units of the Reporting Person acquired by an individual. Read SEC document |
| June 30, 2017 Filed Aug 9, 2018 20:56 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | OtherCommon Stock | 27,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-000255 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,182,547 F1 · kind: Issuer shares were disposed of by the Reporting Person through an in-kind exchange of incentive units of the Reporting Person acquired by employees of entities affiliated with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.